Video

Prevalence and Characteristics of GI Cancers

Syma Iqbal, MD, provides insights pertaining to various types of upper GI cancers, as well as primary characteristics and risk factors for these diseases.

Syma Iqbal, MD: The most common upper GI [gastrointestinal] cancers are esophageal cancer—there are 2 common pathologies: adenocarcinoma and squamous cell carcinoma—and gastric cancer, which is generally adenocarcinoma. There are about 20,000 cases of esophageal cancer per year, and about 25,000 cases of gastric cancer per year. Relatively speaking, that’s the incidence of these diseases as well.

Screening around upper GI cancers doesn’t really exist in the West. These cancers are quite common in Asian countries, so there are screening parameters routinely implemented into the standard of care in the Asian world, largely Japan and Korea. But in the West, there aren’t standards for screening. There’s likely higher incidence of these diseases in our Asian populations, but we don’t have that incorporated into our standard of care. In terms of diagnoses, unfortunately, most patients present with advanced disease. Symptoms may be present, but they’re treated with PPIs [proton pump inhibitors] or H2 blockers for prolonged periods of time, and alarming symptoms often can be missed.

With patients in the Western world who present with upper GI malignancies, specifically esophageal cancer, we’re seeing a decreased incidence of squamous cell carcinoma, which is largely associated with alcohol use and tobacco use. That incidence has been decreasing over the last several years, likely due to lifestyle modifications associated with smoking and drinking. But adenocarcinoma of the esophagus is increasing in incidence in the Western world, which probably has more to do with obesity, GERD [gastroesophageal reflux disease], and high BMIs [body mass indexes] in these patient populations. Reflux disease is contributing to that.

In gastric cancer, the major risk factors are around Helicobacter pylori. Other risk factors include smoking; some alcohol use, although perhaps controversial; nitrates; and smoked foods. The incidence of gastric cancer has been decreasing in the Western world, which has been attributed to things like better refrigeration and clean water. Probably our biggest risk factor for gastric cancer, even in the Western world, is still H pylori.

There are also genetic syndromes that put patients at risk for developing gastric cancer in particular. Although this is a smaller incidence, those gastric cancers that are associated with underlying genetic syndromes do occur. Those include syndromes such as hereditary nonpolyposis coli, or Lynch syndrome. BRCA syndromes are associated with gastric cancer. There’s a hereditary gastric cancer syndrome, which is CDH1 mutation; TP53 mutations, or Li-Fraumeni syndrome; the polyposis syndromes, such as FAP [familial adenomatous polyposis]; and the variants are also associated with developing gastric cancer in particular.

Transcript edited for clarity.

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
Justin Oldham, MD, MS, an expert on IPF
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
Justin Oldham, MD, MS, an expert on IPF
Ruben Mesa, MD
Amit Garg, MD, Northwell Health
4 KOLs are featured in this series
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo